The US is split over right to work laws—literally. Exactly half of the 50 states are right-to-work states—the next will tip the balance.
Why it is more important than ever today, as both a buyer and a seller, to know your market well and know its housing value even better.
The Dow fell 115 points on Friday, weighed by data and Greece.
Silk Road creator Ross Ulbricht has been sentenced to life in prison in connection with his operation of the website.
American Express President Ed Gilligan died suddenly Friday after falling ill while flying on a corporate plane to New York.
Assets in 529 college savings plan are near record highs and lawmakers want to expand the plans' tax benefits.
As a selling wave hit stocks Friday, traders chatted up a market factoid that appeared to lay the blame for the decline on month end maneuvers.
Independent investment consultant David Darst believes there are three things holding back this "Sleeping Beauty" market.
A study reveals that the median pay of female CEOs increased by 21 percent compared to last year.
BofA Merrill Lynch's David Woo said that we are currently in the middle of a currency war in which the Fed is unable to play.
RBC's chief U.S. market strategist says that investors who obsess over historical valuations are missing the point.
CNBC Pro highlights the top performing stocks this week and analyzes whether the good times will continue.
Incyte stands to benefit from unveiling data on its cancer treatments at a conference in the coming days, a biotech analyst said.
"The True Cost," an eye-opening documentary that examines the business of fast fashion, scrutinizes the process every step of the way.
Texas is forgoing about $100 billion in federal funds by not expanding a major health program for the poor.
Former JC Penney CEO Allen Questrom explains why Michael Kors' stock has dropped so much and why it's an industry-wide problem.
Farms across Texas and surrounding states are flooded and waterlogged, leaving farmers who had been looking at bumper crops now worried.
The Fed's monetary policy is behind the curve once more, says Michael Farr.
Legendary trader Laszlo Birinyi sees all the bearish talk from his peers and the media and takes the opposite view.
Meg Tirrell tells us why the future of cancer therapy may almost be here.